Foresite 关于Candid 的故事:
We atForesite Capitalare still buzzing from yesterday’s announcement and wanted to once again congratulateCandid Therapeuticson their acquisition byUCBfor $2B+.
可以去他们官网看原文。老外的资金组合效率,我们是前端早研创新药输出。ken company
发布于 上海
